DLL4 loss-of-function heterozygous mutations cause Adams-Oliver syndrome

Affiliations

¹ Department of Medical Genetics, Center for Molecular Medicine and Therapeutics, The Canadian Pharmacogenomic Network for Drug Safety, Vancouver, Canada. folefac@cmmt.ubc.ca.

Comment

F Aminkeng. Clin Genet. 2015 Dec.

. 2015 Dec;88(6):532.

doi: 10.1111/cge.12681. Epub 2015 Oct 16.

¹ Department of Medical Genetics, Center for Molecular Medicine and Therapeutics, The Canadian Pharmacogenomic Network for Drug Safety, Vancouver, Canada. folefac@cmmt.ubc.ca.

No abstract available

Comment on

Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome.
Meester JA, Southgate L, Stittrich AB, Venselaar H, Beekmans SJ, den Hollander N, Bijlsma EK, Helderman-van den Enden A, Verheij JB, Glusman G, Roach JC, Lehman A, Patel MS, de Vries BB, Ruivenkamp C, Itin P, Prescott K, Clarke S, Trembath R, Zenker M, Sukalo M, Van Laer L, Loeys B, Wuyts W. Meester JA, et al. Am J Hum Genet. 2015 Sep 3;97(3):475-82. doi: 10.1016/j.ajhg.2015.07.015. Epub 2015 Aug 20. Am J Hum Genet. 2015. PMID: 26299364 Free PMC article.